The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Cytokines in Cancer Immunotherapy
Open accessAbstract
Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been accompanied by heightened efforts to characterize cytokines and exploit their vast signaling networks to develop cancer treatments. The goal of this paper is to review the major cytokines involved in cancer immunotherapy and discuss their basic biology and clinical applications. The paper will also describe new cytokines in pre-clinical development, combinations of biological agents, novel delivery mechanisms, and potential directions for future investigation using cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Cellular and Molecular Immunology
Abbas, A. K., Lichtman, A. H., & Pillai, S. S. (1994) · Cited by 3,584
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,094
Atkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048
Self-citationInterferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
Snapper, C. M., & Paul, W. E. (1987) · Science · doi:10.1126/science.3107127 · Cited by 1,920
Sakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465 · cited 2×
“increased risk of spontaneous and chemically-induced tumors compared to controls [1,3,26,61].”
BackgroundThe anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1285 · Cited by 1,255
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., et al. (2000) · Nature · doi:10.1038/35040504 · Cited by 1,224
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Waldmann, T. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1901 · Cited by 1,178
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“In some studies of IFNdepression was highly significant and rare suicides were reported [47].”
BackgroundNew insights into the regulation of T cells by γc family cytokines
Rochman, Y., Spolski, R., & Leonard, W. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2580 · Cited by 1,053
BRAF Mutations in Hairy-Cell Leukemia
Tiacci, E., Trifonov, V., Schiavoni, G., Holmes, A., Kern, W., Martelli, M. P., Pucciarini, A., Bigerna, B., Pacini, R., Wells, V. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014209 · Cited by 1,024
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
El-Omar, E. M., Rabkin, C. S., Gammon, M. D., Vaughan, T. L., Risch, H. A., Schoenberg, J. B., Stanford, J. L., Mayne, S. T., Goedert, J., Blot, W. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00157-4 · Cited by 917
Kirkwood, J. M., Ibrahim, J. G., Sondak, V. K., Richards, J., Flaherty, L. E., Ernstoff, M. S., Smith, T. J., Rao, U., Steele, M., & Blum, R. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2444 · Cited by 912
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012863 · Cited by 911
Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H., Lanier, L. L., Groh, V., Spies, T., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.020 · Cited by 855
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis
Chawla-Sarkar, M., Lindner, D. J., Liu, Y.-F., Williams, B. R., Sen, G. C., Silverman, R. H., & Borden, E. C. (2003) · Apoptosis · doi:10.1023/a:1023668705040 · Cited by 829
Control of Homeostasis of CD8 + Memory T Cells by Opposing Cytokines
Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J., & Marrack, P. (2000) · Science · doi:10.1126/science.288.5466.675 · Cited by 816
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
Puel, A., Ziegler, S. F., Buckley, R. H., & Leonard., W. J. (1998) · Nature Genetics · doi:10.1038/3877 · Cited by 813
T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells
Lighvani, A. A., Frucht, D. M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B. D., Nguyen, B. V., Gadina, M., Sher, A., Paul, W. E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261570598 · Cited by 783 · cited 1×
“IFN- is secreted by NK cells, NKT cells, Th1 CD4+ T-cells, CD8+ T cells, antigen presenting cells (APCs) and B-cells [55,56].”
BackgroundYoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., & Nakanishi, K. (1998) · PubMed · Cited by 770
Boni, A., Cogdill, A. P., Dang, P., Udayakumar, D., Njauw, C.-N. J., Sloss, C. M., Ferrone, C. R., Flaherty, K. T., Lawrence, D. P., Fisher, D. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0118 · Cited by 742
Waldmann, T. A., & Tagaya, Y. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.19 · Cited by 721
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
Daud, A. I., DeConti, R. C., Andrews, S., Urbas, P., Riker, A. I., Sondak, V. K., Munster, P. N., Sullivan, D. M., Ugen, K. E., Messina, J. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6794 · Cited by 701
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675
TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2742 · Cited by 624
Senzer, N. N., Kaufman, H. L., Amatruda, T., Nemunaitis, M., Reid, T., Daniels, G., Gonzalez, R., Glaspy, J., Whitman, E., Harrington, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.3675 · Cited by 616
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
de Waal Malefyt, R., Yssel, H., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4754 · Cited by 603
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Harnessing the biology of IL-7 for therapeutic application
Mackall, C. L., Fry, T. J., & Gress, R. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2970 · Cited by 571
Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., Guest, P. J., Harrington, K. J., James, N. D., Love, C. A., McNeish, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0759 · Cited by 569
Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon
Gogas, H., Ioannovich, J., Dafni, U., Stavropoulou-Giokas, C., Frangia, K., Tsoutsos, D., Panagiotou, P., Polyzos, A., Papadopoulos, O., Stratigos, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053007 · Cited by 566
Thornton, A. M., Donovan, E. E., Piccirillo, C. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6519 · Cited by 560
Kirkwood, J. M., Manola, J., Ibrahim, J., Sondak, V., Ernstoff, M. S., & Rao, U. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1103-3 · Cited by 552
Tregs and rethinking cancer immunotherapy
Curiel, T. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31202 · Cited by 547
Control of T‐cell activation by CD4+ CD25+ suppressor T cells
Shevach, E. M., McHugh, R. S., Piccirillo, C. A., & Thornton, A. M. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820104.x · Cited by 546
Mocellin, S., Pasquali, S., Rossi, C. R., & Nitti, D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq009 · Cited by 527
Regulation of interferon-γ production by IL-12 and IL-18
Okamura, H., Kashiwamura, S.-I., Tsutsui, H., Yoshimoto, T., & Nakanishi, K. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80163-5 · Cited by 523
Kaufman, H. L., Kim, D. W., DeRaffele, G., Mitcham, J., Coffin, R. S., & Kim-Schulze, S. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0809-6 · Cited by 518
Jonasch, E., & Haluska, F. G. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-34 · Cited by 518
Prognostic significance of autoimmunity during treatment of melanoma with interferon
Krauze, M. T., Tarhini, A., Gogas, H., & Kirkwood, J. M. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0247-y · Cited by 507
Trikha, M., Corringham, R. E., Klein, B., & Rossi, J. (2003) · PubMed · Cited by 506
Direct Effects of Type I Interferons on Cells of the Immune System
Hervas-Stubbs, S., Perez-Gracia, J. L., Rouzaut, A., Sanmamed, M. F., Le Bon, A., & Melero, I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1114 · Cited by 503
The Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
IFN-γ production by antigen-presenting cells: mechanisms emerge
Frucht, D. M., Fukao, T., Bogdan, C., Schindler, H., O'Shea, J. J., & Koyasu, S. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02005-1 · Cited by 461
Luster, A. D., Greenberg, S. M., & Leder, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.219 · Cited by 446
Rosenberg, S. A., Sportès, C., Ahmadzadeh, M., Fry, T. J., Ngo, L. T., Schwarz, S. L., Stetler-Stevenson, M., Morton, K. E., Mavroukakis, S. A., Morre, M., et al. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000210386.55951.c2 · Cited by 443
Fisher, R. I., Rosenberg, S. A., & Fyfe, G. (2000) · PubMed · Cited by 439
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
Marks-Konczalik, J., Dubois, S., Losi, J. M., Sabzevari, H., Yamada, N., Feigenbaum, L., Waldmann, T. A., & Tagaya, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200363097 · Cited by 433
Numasaki, M., Watanabe, M., Suzuki, T., Takahashi, H., Nakamura, A., McAllister, F., Hishinuma, T., Goto, J., Lotze, M. T., Kolls, J. K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6177 · Cited by 416
Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., & Lee, W. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1555 · Cited by 415
Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating Factor
Grabstein, K. H., Urdal, D. L., Tushinski, R. J., Mochizuki, D. Y., Price, V. L., Cantrell, M. A., Gillis, S., & Conlon, P. J. (1986) · Science · doi:10.1126/science.3083507 · Cited by 412
Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer
Atkins, M. B., Regan, M. M., McDermott, D. F., Mier, J. W., Stanbridge, E. J., Youmans, A. J., Febbo, P. G., Upton, M. P., Lechpammer, M., & Signoretti, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2019 · Cited by 402
The Interferons: 50 Years after Their Discovery, There Is Much More to Learn
Pestka, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700004200 · Cited by 392
Krieg, C., Létourneau, S., Pantaleo, G., & Boyman, O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002569107 · Cited by 380
Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
Street, S. E. A., Trapani, J. A., MacGregor, D., & Smyth, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020063 · Cited by 375
McCart, J. A., Ward, J. M., Lee, J., Hu, Y., Alexander, H. R., Libutti, S. K., Moss, B., & Bartlett, D. L. (2001) · PubMed · Cited by 366
Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
Fernández‐Rivas, M., González-Mancebo, E., Rodríguez-Pérez, R., Benito, C., Sánchez-Monge, R., Salcedo, G., Alonso, M. D., Rosado, A., Tejedor, M. A., Vila, C., et al. (2003) · PubMed · doi:10.1016/s0091 · Cited by 357
Sakamaki, K., Miyajima, I., Kitamura, T., & Miyajima, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05437.x · Cited by 341
Perussia, B., Chan, S. H., D’Andrea, A., Tsuji, K., Santoli, D., Pospisil, M., Young, D., Wolf, S. F., & Trinchieri, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3495 · Cited by 324
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Slingluff, C. L., Petroni, G. R., Yamshchikov, G. V., Barnd, D. L., Eastham, S., Galavotti, H., Patterson, J. W., Deacon, D. H., Hibbitts, S., Teates, D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.005 · Cited by 322
Tsutsui, H., Matsui, K., Kawada, N., Hyodo, Y., Hayashi, N., Okamura, H., Higashino, K., & Nakanishi, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.3961 · Cited by 321
Soiffer, R., Hodi, F. S., Haluska, F., Jung, K., Gillessen, S., Singer, S., Tanabe, K., Duda, R., Mentzer, S., Jaklitsch, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.005 · Cited by 305
Tartour, É., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E. J., Sastre‐Garau, X., Couturier, J., Mosseri, V., Vives, V., et al. (1999) · PubMed · Cited by 290
Chawla‐Sarkar, M., Leaman, D. W., & Borden, E. C. (2001) · PubMed · Cited by 289
Inhibition of endothelial cell proliferation by gamma-interferon.
Friesel, R., Komoriya, A., & Maciag, T. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.3.689 · Cited by 287
Gollob, J., Mier, J. W., Veenstra, K. G., McDermott, D. F., Clancy, D., Clancy, M., & Atkins, M. B. (2000) · PubMed · Cited by 285
Golgher, D., Jones, E., Powrie, F., Elliott, T., & Gallimore, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3267::aid-immu3267>3.0.co;2-1 · Cited by 282
The First 1000 Dendritic Cell Vaccinees
Ridgway, D. (2003) · Cancer Investigation · doi:10.1081/cnv-120025091 · Cited by 278
Chan, S. H., Kobayashi, M., Santoli, D., Perussia, B., & Trinchieri, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.1.92 · Cited by 276
IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response
Li, Y., Bleakley, M., & Yee, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2261 · Cited by 273
Biology of common β receptor–signaling cytokines
Shearer, W. T., Rosenwasser, L. J., Bochner, B. S., Martinez-Moczygemba, M., & Huston, D. P. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.015 · Cited by 264
Evidence of IL-18 as a Novel Angiogenic Mediator
Park, C. C., Morel, J. C. M., Amin, M. A., Connors, M. A., Harlow, L. A., & Koch, A. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1644 · Cited by 263
Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
Yin, T., Taga, T., Tsang, M. L., Yasukawa, K., Kishimoto, T., & Yang, Y. C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2555 · Cited by 262
Blay, J.-Y., Rossi, J.-F., Wijdenes, J., Menetrier-Caux, C., Schemann, S., Négrier, S., Philip, T., & Favrot, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970729)72:3<424::aid-ijc9>3.0.co;2-r · Cited by 261
Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool
Melchionda, F., Fry, T. J., Milliron, M. J., McKirdy, M. A., Tagaya, Y., & Mackall, C. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523134 · Cited by 246
Interleukin-21 inhibits dendritic cell activation and maturation
Brandt, K., Bulfone-Paus, S., Foster, D. C., & Rückert, R. (2003) · Blood · doi:10.1182/blood-2003-03-0669 · Cited by 245
Safety and immunologic effects of IL-15 administration in nonhuman primates
Berger, C., Berger, M., Hackman, R. C., Gough, M., Elliott, C., Jensen, M. C., & Riddell, S. R. (2009) · Blood · doi:10.1182/blood-2008-12-189266 · Cited by 244
c-myc Is a Downstream Target of the Smad Pathway
Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., & Kato, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104170200 · Cited by 244
In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells
Prlic, M., Blazar, B. R., Farrar, M. A., & Jameson, S. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021847 · Cited by 243
Differences in signaling pathways by IL-1β and IL-18
Lee, J.-K., Kim, S.-H., Lewis, E. C., Azam, T., Reznikov, L. L., & Dinarello, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402800101 · Cited by 237
Next Generation of Immunotherapy for Melanoma
Kirkwood, J. M., Tarhini, A. A., Panelli, M. C., Moschos, S. J., Zarour, H. M., Butterfield, L. H., & Gogas, H. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.6423 · Cited by 227
In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
Wang, G., Tschoi, M., Spolski, R. J., Lou, Y., Ozaki, K., Feng, C., Kim, G., Leonard, W. J., & Hwu, P. (2003) · PubMed · Cited by 221
Kaufman, H. L., & Bines, S. D. (2010) · Future Oncology · doi:10.2217/fon.10.66 · Cited by 209
Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes
Kotenko, S. V., & Pestka, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203524 · Cited by 205
McNally, A., Hill, G. R., Sparwasser, T., Thomas, R., & Steptoe, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103782108 · Cited by 201
Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
Achyut, B. R., & Yang, L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.048 · Cited by 199
Jinushi, M., Nakazaki, Y., Dougan, M., Carrasco, D. R., Mihm, M., & Dranoff, G. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30966 · Cited by 195
Voorzanger‐Rousselot, N., Touitou, R., Garcia, E., Delecluse, H., Rousset, F., Joab, I., Favrot, M., & Blay, J. (1996) · PubMed · Cited by 192
Chehimi, J., Starr, S. E., Frank, I., Rengaraju, M., Jackson, S. J., Llanes, C., Kobayashi, M., Perussia, B., Young, D., & Nickbarg, E. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.789 · Cited by 188
The functional characterization of interleukin-10 receptor expression on human natural killer cells
Carson, W., Lindemann, M., Baiocchi, R., Linett, M., Tan, J., Chou, C., Narula, S., & Caligiuri, M. (1995) · Blood · doi:10.1182/blood.v85.12.3577.bloodjournal85123577 · Cited by 187
Borden, E. C., Hogan, T. F., & Voelkel, J. G. (1982) · PubMed · Cited by 186
Guidelines for the Safe Administration of High-Dose Interleukin-2
Schwartzentruber, D. J. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200107000-00004 · Cited by 182 · cited 1×
“diarrhea [83].”
Th17 cells in cancer: help or hindrance?
Wilke, C. M., Kryczek, I., Wei, S., Zhao, E., Wu, K., Wang, G., & Zou, W. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr019 · Cited by 180
TGF-β/SMAD/GLI2 Signaling Axis in Cancer Progression and Metastasis
Javelaud, D., Alexaki, V. I., Dennler, S., Mohammad, K. S., Guise, T. A., & Mauviel, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1194 · Cited by 178
Sabatino, M., Kim-Schulze, S., Panelli, M. C., Stroncek, D., Wang, E., Taback, B., Kim, D. W., DeRaffele, G., Pos, Z., Marincola, F. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1106 · Cited by 171
GM-CSF-secreting melanoma vaccines
Dranoff, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206459 · Cited by 166
Le, D. T., Pardoll, D. M., & Jaffee, E. M. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eb33d7 · Cited by 157
Interleukin-2: Clinical applications
Atkins, M. B. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.33077 · Cited by 156 · cited 1×
“melanoma and durable complete responses in 5–7% of these patients [80,81].”
BackgroundSchandené, L., Prete, G., Cogan, E., Stordeur, P., Crusiaux, A., Kennès, B., Romagnani, S., & Goldman, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118417 · Cited by 153
Johns, T. G., Mackay, I. R., Callister, K. A., Hertzog, P. J., Devenish, R. J., & Linnance, A. W. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.15.1185 · Cited by 148
Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why?
Groettrup, M., Khan, S., Schwarz, K., & Schmidtke, G. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01251-2 · Cited by 147
Interferon-γ and Cancer Immunoediting
Dunn, G. P., Ikeda, H., Bruce, A. T., Koebel, C. M., Uppaluri, R., Bui, J. D., Chan, R., Diamond, M. S., White, J. M., Sheehan, K. C. F., et al. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:231 · Cited by 147
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factor.
Small, E. J., Reese, D., Um, B., Whisenant, S. P., Dixon, S. C., & Figg, W. D. (1999) · PubMed · Cited by 145
A Critical Role for IL-18 in the Proliferation and Activation of NK1.1+CD3− Cells
Tomura, M., Zhou, X., Maruo, S., Ahn, H., Hamaoka, T., Okamura, H., Nakanishi, K., Tanimoto, T., Kurimoto, M., & Fujiwara, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4738 · Cited by 138
Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines
Beatty, P. R., Krams, S. M., & Martinez, O. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4045 · Cited by 136
Tomura, M., Maruo, S., Mu, J., Zhou, X., Ahn, H., Hamaoka, T., Okamura, H., Nakanishi, K., Clark, S., Kurimoto, M., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3759 · Cited by 128
IL-21: a novel IL-2–family lymphokine that modulates B, T, and natural killer cell responses
Habib, T., Nelson, A., & Kaushansky, K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.039 · Cited by 127
Zaanen, V., Lokhorst, Aarden, Rensink, Warnaar, Lelie, V. D., & van Oers, M. H. J. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00835.x · Cited by 127
Rao, J. B., Chamberlain, R. S., Bronte, V., Carroll, M. W., Irvine, K. R., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3357 · Cited by 125
Yuan, X., Hu, J., Belladonna, M. L., Black, K. L., & Yu, J. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1682 · Cited by 121
Tomura, M., Maruo, S., Mu, J., Zhou, X., Ahn, H., Hamaoka, T., Okamura, H., Nakanishi, K., Clark, S., Kurimoto, M., et al. (1998) · PubMed · Cited by 119
Production of interleukin-10 by human bronchogenic carcinoma.
Smith, D. R., Kunkel, S. L., Burdick, M. D., Wilke, C. A., Orringer, M., Whyte, R. I., & Strieter, R. M. (1994) · PubMed Central · Cited by 116
Basham, T. Y., Bourgeade, M., Creasey, A. A., & Merigan, T. C. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3265 · Cited by 116
Interleukin 10 production by human melanoma.
Sato, T., McCue, P. A., Masuoka, K., Salwen, S. A., Lattime, E. C., Mastrangelo, M. J., & Berd, D. (1996) · PubMed · Cited by 112
Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial
Mahvi, D. M., Henry, M. B., Albertini, M. R., Weber, S. M., Meredith, K. L., Schalch, H., Rakhmilevich, A. L., Hank, J. A., & Sondel, P. M. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701064 · Cited by 112
Kishida, T., Asada, H., Itokawa, Y., Cui, F.-D., Shin‐Ya, M., Gojo, S., Yasutomi, K., Ueda, Y., Yamagishi, H., Imanishi, J., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00222-3 · Cited by 112
Constantinescu, S. N., Croze, E., Wang, C., Murti, A., Basu, L., Mullersman, J. E., & Pfeffer, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9602 · Cited by 108
Sosman, J. A., Carrillo, C., Urba, W. J., Flaherty, L. E., Atkins, M. B., Clark, J. I., Dutcher, J., Margolin, K. A., Mier, J. W., Gollob, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3165 · Cited by 104
Self-citationYu, J. S., Yuan, X., Liu, G., Zeng, Z., Morris-Irvin, D., & Black, K. L. (2005) · Neurosurgery · doi:10.1093/neurosurgery/57.2.411a · Cited by 104
Strengell, M., Lehtonen, A., Matikainen, S., & Julkunen, I. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905503 · Cited by 101
Kaiga, T., Sato, M., Kaneda, H., Iwakura, Y., Takayama, T., & Tahara, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7571 · Cited by 97
Jinushi, M., Hodi, F. S., & Dranoff, G. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00618.x · Cited by 91
Vilček, J. (2002) · Nature Immunology · doi:10.1038/ni0103-8 · Cited by 91
Ugurel, S., Schrama, D., Keller, G., Schadendorf, D., Bröcker, E.-B., Houben, R., Zapatka, M., Fink, W., Kaufman, H. L., & Becker, J. C. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0407-z · Cited by 88
Serum lipids regulate dendritic cell CD1 expression and function
Leslie, D. S., Dascher, C. C., Cembrola, K., Townes, M. A., Hava, D. L., Hugendubler, L., Mueller, E., Fox, L. M., Roura‐Mir, C., Moody, D. B., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02842.x · Cited by 86
Foster, D. C., Paus, R., Brandt, K., Bulfone‐Paus, S., Jenckel, A., & Rückert, R. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12603.x · Cited by 85
Dolei, A., Capobianchi, M. R., & Ameglio, F. (1983) · Infection and Immunity · doi:10.1128/iai.40.1.172-176.1983 · Cited by 83
Inhibition of in vitro angiogenesis by lymphotoxin and interferon-γ
Tsuruoka, N., Sugiyama, M., Tawaragi, Y., Tsujimoto, M., Nishihara, T., Goto, T., & Sato, N. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81104-5 · Cited by 80
Bouwhuis, M. G., Suciu, S., Collette, S., Aamdal, S., Kruit, W. H. J., Bastholt, L., Stierner, U. K., Salès, F., Patel, P. M., Punt, C. J. A., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp132 · Cited by 77
Carlo, E. D., Comes, A., Basso, S., Ambrosis, A. D., Meazza, R., Musiani, P., Moelling, K., Albini, A., & Ferrini, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3111 · Cited by 75
Colombetti, S., Lévy, F., & Chapatte, L. (2009) · Blood · doi:10.1182/blood-2008-05-155309 · Cited by 75
Wagner, T. C., Velichko, S., Chesney, S. K., Biroc, S. L., Russell-Harde, D., Vogel, D., & Croze, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.20236 · Cited by 73
In vitro studies with bendamustine: Enhanced activity in combination with rituximab
Rummel, M., Chow, K. U., Hoelzer, D. F., Mitrou, P. S., & Weidmann, E. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.34873 · Cited by 73
Hermanns, H. M., Radtke, S., Haan, C., Schmitz-Van de Leur, H., Tavernier, J., Heinrich, P. C., & Behrmann, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6651 · Cited by 71
Santin, A. D., Bellone, S., Ravaggi, A., Roman, J. J., Smith, C. V., Pecorelli, S. L., Cannon, M. J., & Parham, G. P. (2001) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s0306-5456(00)00206-0 · Cited by 70
He, H., Wisner, K. P., Yang, G., Hu, H., Haley, D., Miller, W., O’Hara, A. C., Alvord, W. G., Clegg, C. H., Fox, B. A., et al. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-24 · Cited by 69
Control of organ-specific autoimmunity by immunoregulatory CD4+CD25+ T cells
McHugh, R. S., Shevach, E. M., & Thornton, A. M. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01453-8 · Cited by 67
Li, Q., Carr, A., Donald, E. J., Skitzki, J. J., Okuyama, R., Stoolman, L. M., & Chang, A. E. (2005) · Cancer Research · doi:10.1158/0008-5472.1063.65.3 · Cited by 66
Yoshimoto, T., Nagai, N., Ohkusu, K., Ueda, H., Okamura, H., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1483 · Cited by 61
Enhanced Tumor Development in Mice Lacking a Functional Type I Interferon Receptor
Picaud, S., Bardot, B., Maeyer, E. D., & Seif, I. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900252952244 · Cited by 60
Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha.
Jones, T. H., Wadler, S., & Hupart, K. (1998) · PubMed · Cited by 59
Sivakumar, P. V., Foster, D. C., & Clegg, C. H. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01886.x · Cited by 58
Interferon-Lambda as a Potential Therapeutic Agent in Cancer Treatment
Steen, H. C., & Gamero, A. M. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0058 · Cited by 57
gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
Nakashima, K., & Taga, T. (1998) · PubMed · Cited by 56
The Structure of the Interleukin-15α Receptor and Its Implications for Ligand Binding
Lorenzen, I., Dingley, A. J., Jacques, Y., & Grötzinger, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m513118200 · Cited by 56
Kaufman, H. L., Flanagan, K., Lee, C. S. D., Perretta, D. J., & Hörig, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00032-4 · Cited by 55
Structural Plasticity of the Proteasome and Its Function in Antigen Processing
Groettrup, M., van den Broek, M. F., Schwarz, K., Macagno, A., Khan, S., de Giuli, R., & Schmidtke, G. (2001) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v21.i4.30 · Cited by 54
Yoshimoto, T., Nagai, N., Ohkusu, K., et al. (1998) · PubMed · Cited by 53
Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population
Nikolova, P. N., Pawelec, G., Mihailova, S. M., Ivanova, M., Myhailova, A. P., Baltadjieva, D. N., Marinova, D., Ivanova, S. S., & Naumova, E. J. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0193-z · Cited by 52
Pockaj, B. A., Topalian, S. L., Steinberg, S. M., White, D. E., & Rosenberg, S. A. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.136 · Cited by 50
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction
Hodi, F. S., Schmollinger, J. C., Soiffer, R. J., Salgia, R., Lynch, T. J., Ritz, J., Alyea, E. P., Yang, J., Neuberg, D. S., Mihm, M. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102025999 · Cited by 49
Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity
Jovasevic, V. M., Gorelik, L., Bluestone, J. A., & MOKYR, M. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1449 · Cited by 46
Voss, S., Hank, J. A., Nobis, C., et al. (1989) · Cancer Immunology Immunotherapy · doi:10.1007/bf00199214 · Cited by 43
Satomi, H., Wang, B., Fujisawa, H., & Otsuka, F. (2002) · Cytokine · doi:10.1006/cyto.2002.1028 · Cited by 42
Yamane, B. H., Hank, J. A., Albertini, M. R., & Sondel, P. M. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903048911 · Cited by 38
Immunomodulatory and antitumor effects of interleukin-21 in patients with renal cell carcinoma
Curti, B. D. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.6.905 · Cited by 34
Interferon response pathways—a paradigm for cytokine signalling?
Müller, M. M., Ibelgaufts, H., & Kerr, I. M. (1994) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1994.tb00109.x · Cited by 33
Signaling from cytokine receptors that affect TH1 responses
Allison, M. H. (2002) · Frontiers in bioscience · doi:10.2741/hanlon · Cited by 33
Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output.
Beekman, J., Verhagen, L., Geijsen, N., & Coffer, P. (2009) · Blood · doi:10.1182/blood-2009-03-208850 · Cited by 32
Efficacy of local versus systemic application of antibody-cytokine fusion proteins in tumor therapy.
Christ, O., Seiter, S., Matzku, S., Burger, C., & Zöller, M. (2001) · PubMed · Cited by 32
Interleukin-10 Gene Expression and Adult T-Cell Leukemia
Mori, N., & Prager, D. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809068561 · Cited by 29
Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma
Ortegel, J. W., Staren, E. D., Faber, L. P., Warren, W. H., & Braun, D. P. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050011 · Cited by 29
Jackaman, C., & Nelson, D. J. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2009.85 · Cited by 17
(2000) · doi:10.1002/1097-0142(20000715)89:2
Cited by
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Delivery technologies for cancer immunotherapy
Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,607
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Metadata
- Authors
- Lee, S., & Margolin, K.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2011-10-13
- Volume
- 3
- Issue
- 4
- Pages
- 3856-3893
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W1997383546
- Cited by
- 693
- References
- 187
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.